EMEA, FDA accept common application form for orphan designations

Wednesday 28 November 2007

Companies that wish to develop drugs for rare or life-threatening diseases can now apply for financial incentives from the US and the European Union (EU) using a single application form.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom